Skip to main content
Clinical Trials/NL-OMON42530
NL-OMON42530
Completed
Phase 3

EMG measurements of respiratory muscles for the titration of nocturnal non-invasive ventilation in stable chronic obstructive pulmonary disease patients; a randomised cross-over trial. - Respiratory EMG for NIV titration in stable COPD.

niversitair Medisch Centrum Groningen0 sites12 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
COPD
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
12
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Chronic Obstructive Pulmonary Diseases GOLD stage III or IV (FEV1 \< 50% predicted, FEV1/FVC \< 70% predicted)
  • \- Indication for the initiation of chronic NIV: PaCO2 \> 6\.0 kPa at rest during daytime, in stable condition
  • \- Stable COPD (pH \< 7,35 and no exacerbation in the past two weeks)
  • \- Age \> 18 years

Exclusion Criteria

  • \- Respiratory failure of any other cause, for example concomitant neuromuscular disease.
  • \- Already initiated chronic NIV

Outcomes

Primary Outcomes

Not specified

Similar Trials